Growth Metrics

Quest Diagnostics (DGX) Receivables - Net (2016 - 2026)

Quest Diagnostics' Receivables - Net history spans 18 years, with the latest figure at $1.6 billion for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 13.03% to $1.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.6 billion, a 13.03% increase, with the full-year FY2025 number at $1.4 billion, up 7.98% from a year prior.
  • Receivables - Net hit $1.6 billion in Q1 2026 for Quest Diagnostics, up from $1.4 billion in the prior quarter.
  • Over the last five years, Receivables - Net for DGX hit a ceiling of $1.6 billion in Q1 2026 and a floor of $1.2 billion in Q4 2022.
  • Historically, Receivables - Net has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2024.
  • Biggest five-year swings in Receivables - Net: dropped 16.9% in 2022 and later grew 13.03% in 2026.
  • Tracing DGX's Receivables - Net over 5 years: stood at $1.2 billion in 2022, then rose by 1.26% to $1.2 billion in 2023, then increased by 7.77% to $1.3 billion in 2024, then increased by 7.98% to $1.4 billion in 2025, then rose by 12.71% to $1.6 billion in 2026.
  • Business Quant data shows Receivables - Net for DGX at $1.6 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.5 billion in Q3 2025.